NeuropathyREG-NPNCT07437989
Collection of Demographic, Clinical, and Instrumental Data of Patients With Peripheral Neuropathy Including Neurological Examination Data, Peripheral Nerve Conduction Analysis, and Nerve Electromyography and Ultrasound).
An observational study of Neuropathy, run by Casa di Cura Dott. Pederzoli at 1 site in Italy.
Trial summary
The study involves recording personal, clinical, and instrumental information. The acquisition of the above-mentioned personal and clinical information will be carried out in conjunction with the usual follow-up visits scheduled as part of normal clinical practice. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Neuropathy
- What is being tested?
- peripheral neuropathies
- How many people
- 4,000 participants
- Where
- 1 siteItaly
- Study dates
- 23 Feb 2025to Feb 2035
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: recording all diagnosed peripheral neuropathies of P. Pederzoli Hospital in order to systematically collect demographic and clinical data (including data on diagnostic methods of an electrophysiological, imaging and laboratory nature)
Who may be able to join
- Adult patients (age ≧ 18 years old) able to give consent
- Diagnosis of peripheral nerve disorder
Who cannot join
- 1. The patient is unable to consent for him/herself
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site, 1 recruiting
- Recruiting
Ospedale P. Pederzoli Casa di Cura Privata S.p.A.
Peschiera del Garda, Verona, 37019
Giampietro Zanette, MD, +39 0456444193, urc@ospedalepederzoli.it
About this study
Official title: An Observational Prospective Study on Patients With Peripheral Neuropathies Explored With a Combined Clinical, Neurophysiological and Nerve Ultrasound Approach- REG-NP
The study involves recording personal, clinical, and instrumental information. The acquisition of the above-mentioned personal and clinical information will be carried out in conjunction with the usual follow-up visits scheduled as part of normal clinical practice. At the end of the study, a statistical analysis of the data will be carried out.
Read the detailed description
Patients will be asked to participate in the prospective observational study after being fully informed of its objectives and how they will be pursued. Patient compliance is made official by signing the informed consent form.
Patients will then undergo nerve conduction tests and electromyography, as appropriate, and ultrasound evaluation as per clinical practice.
Prior to the above diagnostic investigations, patients will perform a neurological examination to assess the distribution and severity of neuropat
- Conditions
- Neuropathy
- Being tested
- peripheral neuropathies
- Keywords
- ultrasound, peripheral nervous system, Neurological, Electrodiagnostic, Neuromuscolar ultrasound
- Medical subject headings
- Neurologic Manifestations
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
peripheral neuropathiesOther
the neurophysiological study aimed at studying the function of nerves and nerve ultrasound to evaluate its morphological appearance will be performed. Depending on the outcome of the tests carried out, further blood tests will be ordered to identify the causes of neuropathy and identify the most effective treatment where available.
What is being measured
The primary outcome is the main question the study is designed to answer.
record of all diagnosed peripheral neuropathies
The primary objective of the study is to make a record of all diagnosed peripheral neuropathies that systematically includes and collects demographic and clinical data (including data on diagnostic methods of an electrophysiological, imaging and laboratory nature) most relevant for the diagnostic and prognostic definition of such diseases.
Measured: through study completion, an average of 1 year
Secondary outcomes (2)
assess the additional role of ultrasound in the diagnosis of diseases of the peripheral nervous system
Measured: through study completion, an average of 1 year
Identifying ultrasound parameters of disease severity and/or treatment response
Measured: through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Feb 2026
- Study start23 Feb 2025
- Primary completionFeb 2035 (estimated)
- Study completionFeb 2035 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for NeuropathyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 4,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Casa di Cura Dott. Pederzoli
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07437989
- Sponsor's protocol ID
- 417CET
- Acronym
- REG-NP
- Status last verified
- Feb 2026
- First submitted
- 12 Feb 2026
- Last updated
- 27 Feb 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- An Observational Prospective Study on Patients With Peripheral Neuropathies Explored With a Combined Clinical, Neurophysiological and Nerve Ultrasound Approach- REG-NP
- ClinicalTrials.gov ID
- NCT07437989
- Acronym / sponsor ID
- REG-NP / 417CET
- Conditions
- Neuropathy
- Keywords
- ultrasound, peripheral nervous system, Neurological, Electrodiagnostic, Neuromuscolar ultrasound
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 4,000 participants (estimated)
- Lead sponsor
- Casa di Cura Dott. PederzoliUniversity, hospital or other
- Study start
- 23 Feb 2025 (actual)
- Primary completion
- Feb 2035 (estimated)
- Study completion
- Feb 2035 (estimated)
- First posted
- 27 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study involves recording personal, clinical, and instrumental information. The acquisition of the above-mentioned personal and clinical information will be carried out in conjunction with the usual follow-up visits scheduled as part of normal clinical practice. At the end of the study, a statistical analysis of the data will be carried out.
Detailed description
Patients will be asked to participate in the prospective observational study after being fully informed of its objectives and how they will be pursued. Patient compliance is made official by signing the informed consent form.
Patients will then undergo nerve conduction tests and electromyography, as appropriate, and ultrasound evaluation as per clinical practice.
Prior to the above diagnostic investigations, patients will perform a neurological examination to assess the distribution and severity of neuropat
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- recording all diagnosed peripheral neuropathies of P. Pederzoli Hospital in order to systematically collect demographic and clinical data (including data on diagnostic methods of an electrophysiological, imaging and laboratory nature)
Key inclusion criteria (2 listed)
- Adult patients (age ≧ 18 years old) able to give consent
- Diagnosis of peripheral nerve disorder
Key exclusion criteria (1 listed)
- 1. The patient is unable to consent for him/herself
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| peripheral neuropathiesthe neurophysiological study aimed at studying the function of nerves and nerve ultrasound to evaluate its morphological appearance will be performed. Depending on the outcome of the tests carried out, further blood tests will be ordered to identify the causes of neuropathy and identify the most effective treatment where available. | Other | – |
Primary outcome
record of all diagnosed peripheral neuropathies
Time frame: through study completion, an average of 1 year
The primary objective of the study is to make a record of all diagnosed peripheral neuropathies that systematically includes and collects demographic and clinical data (including data on diagnostic methods of an electrophysiological, imaging and laboratory nature) most relevant for the diagnostic and prognostic definition of such diseases.
2 secondary outcomes
assess the additional role of ultrasound in the diagnosis of diseases of the peripheral nervous system
Time frame: through study completion, an average of 1 year
Identifying ultrasound parameters of disease severity and/or treatment response
Time frame: through study completion, an average of 1 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Neuropathy
Active, not recruitingPhase 3
ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
Ischemic Optic Neuropathy
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Not yet recruitingObservational study
Postural Control and Balance Performance in Patients With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS), Postural Assessment
RecruitingPhase 2
Zanubritnib and Anti-MAG Neuropathy
Anti-MAG IgM-associated Demyelinating Polyneuropathy
Active, not recruiting
The AIUR Trial: Surgical Gloves to Prevent Peripheral Neuropathy
Chemotherapy-induced Peripheral Neuropathy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Ospedale P. Pederzoli Casa di Cura Privata S.p.A.
Peschiera del Garda, Italy
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Neuropathy, run by Casa di Cura Dott. Pederzoli at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
record of all diagnosed peripheral neuropathies (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2026.